Evidence map›Paper›PMID 32345737›Full record

ArticlemSystems2020

Deciphering the Structural Diversity and Classification of the Mobile Tigecycline Resistance Gene

Ruichao Li, Xiaoyu Lu, Kai Peng, Ziyi Liu, Yan Li, Yuan Liu, Xia Xiao, Zhiqiang Wang

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 110 citations in OpenAlex.

  1. Evolution, Mechanisms, and Therapeutic Implications of Mobile Tetracycline Destructases.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Emergence of tigecycline-resistantFrontiers in microbiology · 2025
    Article
  10. Emergence of plasmid-borneMicrobiology spectrum · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024
    Review
  16. Article
  17. Distribution and spread of tigecycline resistance geneFrontiers in cellular and infection microbiology · 2024
    Article
  18. Article
  19. Article
  20. Prevalence and Genomic Characteristics ofMicrobiology spectrum · 2023
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ruichao LiCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Xiaoyu LuCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Kai PengCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Ziyi LiuCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Yan LiCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Yuan LiuCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Xia XiaoCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Zhiqiang WangCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China zqwang@yzu.edu.cn.
Yangzhou University · CNJiangsu Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of novel plasmid-mediated resistance genes constitutes a great public concern. Recently, mobile

Indexed as

Nanopore sequencingresistance plasmidometandem repeatstet(X) variantstigecycline resistance

Identifiers

PMID32345737
PMCPMC7190383
OpenAlexW3020195345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.